IL17A and pulmonary fibrosis: The core targets actively interact with major pathways in pulmonary fibrosis, including TNF, HIF-1, FOXO, AGE-RAGE, PD-L1 expression, VEGF, IL-17, relaxin, ErbB, and EGFR tyrosine kinase inhibitor resistance pathways.